A pilot study of vasculogenic mimicry immunohistochemical expression in intraocular melanoma model

Oncology Reports

Volumn 21, Issue 4, 2009, Pages 989-994

  Chen, Luxia ^a   Zhang, Shiwu ^a   Li, Xiaorong ^a   Sun, Baocun ^a   Zhao, Xiulan ^a   Zhang, Danfang ^a   Zhao, Shaozhen ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Animal model; Melanoma; Microcirculation patterns; Vasculogenic mimicry

Indexed keywords

ACTIVATED CARBON; CD34 ANTIBODY; CD34 ANTIGEN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; CONTROLLED STUDY; ELECTRON MICROSCOPY; FEMALE; IMMUNOHISTOCHEMISTRY; INTRAOCULAR TUMOR; MELANOMA; MELANOMA B16; MICROCIRCULATION; MOLECULAR MIMICRY; MOUSE; NONHUMAN; NUTRIENT SUPPLY; OXYGEN SUPPLY; PERIODIC ACID SCHIFF STAIN; PILOT STUDY; PRIORITY JOURNAL; TUMOR CELL; TUMOR VOLUME; VASCULAR ENDOTHELIUM; VASCULARIZATION; ANIMAL; C57BL MOUSE; DISEASE MODEL; EXPERIMENTAL MELANOMA; EYE TUMOR; ULTRASTRUCTURE;

ANIMALS; ANTIGENS, CD34; DISEASE MODELS, ANIMAL; EYE NEOPLASMS; FEMALE; IMMUNOHISTOCHEMISTRY; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MICROCIRCULATION; MICROSCOPY, ELECTRON;

EID: 67449095771     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000313     Document Type: Article

References (32)

1. Maniotis AJ, Folberg R, Hess A, et al: Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol 155: 739-752, 1999.
2. Folberg R, Hendrix MJC and Maniotis AJ: Vasculogenic mimicry and tumor angiogenesis. Am J Pathol 156: 361-381, 2000.
3. McDonald DM, Munn L and Jain RK: Vasculogenic mimicry: how convincing, how novel, and how significance? Am J Pathol 156: 383-387, 2000.
4. Mueller AJ, Maniotis AJ, Freeman WR, Bartsch D-U, Schaller UC, Bergeron-Lynn G, et al: An orthotopic model for human uveal melanoma in SCID mice. Microvasc Res 64: 207-213, 2002.
5. Zhang S, Zhang D, Wang Y, Zhao W, Guo H, Zhao X, et al: Morphologic research of microcirculation patterns in human and animal melanoma. Med Oncol 23: 3403-3409, 2006.
6. Grossniklaus HE, Dithmar S and Albert DM: Animal models of uveal melanoma. Mel Res 10: 195-211, 2000.
7. Ma D, Gerard R, Li X, Alizadeh H and Niederkorn J: Inhibition of metastasis of intraocular melanomas by adenovirus-mediated gene transfer of plasminogen activator inhibitortype I (PAI-1) in an athymic mouse model. Blood 90: 2738-2746, 1997.
8. Ma D and Niederkorn J: Role of epidermal growth factor receptor in the metastasis of intraocular melanomas. Invest Ophthalmol Vis Sci 39: 1067-1075, 1998.
9. Clarijs R, Otte-Hoaller I, Ruiter DJ and de Waal RMW: Presence of a fluid-conducting meshwork in xenografted cutaneous and primary human uveal melanoma. Invest Ophthalmol Vis Sci 43: 912-918, 2002.
10. Rummelt V, Mehaffey MG, Campbell RJ, Peer J, Bentler SE, Woolson RF, Naumann GO and Folberg R: Microcirculation architecture of metastases from prime ciliary body and choroidal melanomas. Am J Ophthalmol 126: 303-305, 1998.
11. Sharma N, Seftor RE, Seftor EA, Gruman LM, Heidger PM Jr, Cohen MB, et al: Prostatic tumor cell plasticity involves cooperative interactions of distinct phenotypic subpopulations: role in vasculogenic mimicry. Prostate 50: 189-201, 2002.
12. Sun B, Zhang D, Zhang S, Zhang W, Guo H and Zhao X: Hypoxia influences vasculogenic mimicry channel formation and tumor invasion-related protein expression in melanoma. Cancer Lett 249: 188-197, 2007.
13. Sood AK, Fletcher MS, Coffin JE, Yang M, Seftor EA, Gruman LM, et al: Functional role of matrix metalloproteinases in ovarian tumor cell plasticity. Am J Obstet Gynecol 190: 899-909, 2004.
14. Zhang S, Hua G, Zhang D, Zhang W, Zhao X, Ren Y, et al: Microcirculation patterns in different stages of melanoma growth. Oncol Rep 15: 15-20, 2006.
15. Folberg R and Maniotis AJ: Vasculogenic mimicry. APMIS 112: 508-525, 2004.
16. Stephenson J: Mosaic vessels shed cancer clues by the million. Lancet Oncol 2: 130, 2001.
17. Drewa G, Wozqak A, Palgan K, Schacht DO, Grzanka A and Sujkowska R: Influence of quercetin on B16 melanotic melanoma growth in C57Bl/6 mice and on activity of some acid hydrolases in melanoma tissue. Neoplasma 48: 12-18, 2001.
18. Sun B, Zhang S, Zhao X, Zhang W and Hao X: Vasculogenic mimicry is associated with poor survival in patients with mesothelial sarcomas and alveolar rhabdomyosarcomas. Int J Oncol 25: 1609-1614, 2004.
19. Hendrix MJ, Seftor EA and Hess AR: Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma. Nat Rev Cancer 3: 411-421, 2003.
20. Ilmonen S, Kariniemi AL, Vlaykova T, Muhonen T, Pyrhonen S and Asko-Seljavaara S: Prognostic value of tumor vascularity in primary melanoma. Melanoma Res 9: 273-242, 1999.
21. Shirakawa K, Kobayashi H, Sobajima J, Hashimoto D, Shimizu A and Wakasugi H: Inflammatory breast cancer: vasculogenic mimicry and its hemodynamics in an inflammatory breast cancer xenograft model. Breast Cancer Res 5: 136-139, 2003.
22. Hendrix MJ, Seftor EA, Hess AR and Seftor RE: Molecular plasticity of human melanoma cells. Oncogene 22: 3070-3075, 2003.
23. Hendrix MJ, Seftor EA, Kirschmann DA, Quaranta V and Seftor RE: Remodeling of the microenvironment by aggressive melanoma tumor cells. Ann NY Acad Sci 995: 151-161, 2003.
24. Vartanian AA, Burova OS, Stepanova EV, Baryshnikov AY and Lichinitser MR: Melanoma vasculogenic mimicry is strongly related to reactive oxygen species level. Melanoma Res 17: 370-379, 2007.
25. Schaft DW, Seftor RE, Seftor EA, Hess AR, Gruman LM, Kirschmann DA, et al: Effects of angiogenesis inhibitors on vascular network formation by human endothelial and melanoma cells. J Natl Cancer Inst 96: 1473-1477, 2004.
26. Hess AR, Seftor EA, Gruman LM, Kinch MS, Seftor RE and Hendrix MJ: VE-cadherin regulates EphA2 in aggressive melanoma cells through a novel signaling pathway: implications for vasculogenic mimicry. Cancer Biol Ther 5: 228-233, 2006.
27. Seftor RE, Seftor EA, Kirschmann DA and Hendrix MJ: Targeting the tumor microenvironment with chemically modified tetracyclines: inhibition of laminin 5 gamma2 chain promigratory fragments and vasculogenic mimicry. Mol Cancer Ther 1: 1173-1179, 2002.
28. Sun B, Zhang S, Zhang D, Gu Y, Zhang W and Zhao X: The influence of different microenvironments on melanoma invasiveness and microcirculation patterns: an animal experiment study in the mouse model. J Cancer Res Clin Oncol 133: 979-985, 2007.
29. Pietras K, Ostman A, Sjoquist M, Buchdunger E, Reed RK, Heldin CH, et al: Inhibition of platelet-derived growth factor receptors reduces interstitial hypertension and increases transcapillary transport in tumors. Cancer Res 61: 2929-2934, 2001.
30. Saif MV: Anti-angiogenesis therapy in pancreatic carcinoma. JOP 7: 163-173, 2006.
31. Hillen F and Griffioen AW: Tumour vascularization: sprouting angiogenesis and beyond. Cancer Metastasis Rev 26: 489-502, 2007.
32. Schachter J, Katz U, Mahrer A, Barak D, David LZ, Nusbacher J, et al: Efficacy and safety of intravenous immunoglobulin in patients with metastatic melanoma. Ann NY Acad Sci 1110: 305-314, 2007.